View
322
Download
0
Embed Size (px)
DESCRIPTION
Presentation given by Sergio Figueiras from Ramón Domínguez Foundation in the framework of the Emergence Forum Barcelona Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation. More information at: http://www.b2match.eu/emergenceforum2014
Citation preview
InnovaSuMMa and PRIS projects: Health Innovation through Precomercial Public Procurement (PCP)
Thursday 10th April, 2014
1. PRIS Project
• Management: Agreement with the Ministry of Economy and Competitiveness
H2050 e Innova Saúde projects
Characteristics 2x45 M€
• Objectives: • Provide the Galician public Health System with innovative
products and services • Foster innovation in companies through Innovative Public
Procurement (IPP)
• Temporal Scope: 2012-2015
• Financing: Regional Development Funds, within the Operational R&D&i Plan – Technological Fund 2007-2013 (80% ERDF)
PRIS Methodology
CPP
Pre-screening
Phase 0
32 projects
Projects with results and potential to reach the market •New therapies •Diagnostic tools •Medical software •Mediacal devices •Health services
With external experts and focused on the market
Working with innovative companies with capacities and technologies that cover Research Groups development needs. Sharing Risks and benefits
Evaluation
PHASE I
20 projects
Elaboration Business Plan
PHASE II
10 projects
Co-development PPP financed through PCP
PHASE II
4-5 projects
Fase 0
Fase I
PRIS Porfolio-Phase 1
PRIS Porfolio Phase 2 and 3
Type of services demanded PROJECTS € investment
CRO 4 projects 3, 8, 30 330.000,00
Medical device companies 2 projects 17, 27 300.000,00
Vaccine GMP manufacturer 1 project 28 150.000,00
Serious Games/Media Company 1 project 16 120.000,00 Preformulation and Drug development company 1 project 6 200.000,00
Pharmaceutical company (Nephrology) 1 project 14 85.000,00
Total projected investments (just private sector) 1.185.000,00
PRIS Budget
2. InnovaSuMMa Project
InnovaSuMMa project
8
• Continuing with previous experience in Galicia in PPI
• InnovaSumma : based on the project developed by ASEBIO and adapted SERGAS priorities
• Inspired in other European PCP projects
• Aiming the introduction of technologies based on biomarkers for new patient assistance protocols based on Personalized medicine for Oncology
9
Changing traditional procurement practices
Legal experts Procurement
Oncology Doctors Galician
Oncology Society
Industrial Association
Health Assistance Director
Technology evaluation
Project management
MINECO Health Innovation
Director
10
Project executed in 3 stages /budget
Stage 1 (opened to 8-10 companies ): 1month-long. scientific-technological proposals and the proposed work plan to the selected Galician Oncology services
Stage 2 (opened to 6 companies): Six months-long. Evaluating the most promising projects resulting from phase 1, with real patients. Proving the selected technologies in real clinical environments
Stage 3 (opened to 4 company): Six months-long. . Full deployment of the best technologies to evaluate the potential of biomarkers and change current clinical protocols in the area of oncology.
Maximum budget per company
Maximum number of companies
PHASE 1 6.000,00 € 8
PHASE 2 70.000,00 € 6
PHASE 3 40.000,00 € 4
TOTAL BUDGET 628.000,00€
InnovaSuMMa Budget
Thank you!
Sergio Figueiras [email protected]